NCT02622880View on ClinicalTrials.gov

Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Head and Neck Neoplasms
Interventions
DIETARY_SUPPLEMENT

immunomodulatory supplement

Experimental Group (immunomodulatory supplement STUDY)

DIETARY_SUPPLEMENT

IMPACT

IMPACT (Nestle Healthcare Nutrition, Minnesota USA) an 'immune-enhancing' feed which contains supplemental L-arginine (1.25 78 g/L), dietary nucleotides (1.2 g/L) and omega-3 fatty acids in the form of 79 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (EPA/DHA 1.7 g/L) 80 as its active ingredients.

Trial Locations (1)

28046

Hospital Universitairo La Paz, Madrid

All Listed Sponsors
collaborator

Vegenat, S.A.

INDUSTRY

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT02622880 - Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients | Biotech Hunter | Biotech Hunter